Dr. Rasmus Münter is a Lead Research Scientist in the Vaccine Adjuvant Systems department of Croda Pharma. He is responsible for developing novel lipid-based adjuvants and self-adjuvating delivery platforms for RNA vaccines. In addition, he runs the functional biological testing of Croda’s novel adjuvant systems. Rasmus holds a Masters degree in Nanoscience from University of Copenhagen and a PhD degree in Drug Delivery from the Technical University of Denmark (DTU). Before joining Croda, he worked on liposomal delivery systems for cancer immunotherapy and RNA-LNPs for in situ generation of CAR-T cells. He has specific expertise within nanoparticle interactions with biological environments (protein corona), single particle studies and anti-PEG allergy.